Industry – Page 6 – Swanson Reed | Specialist R&D Tax Advisors

The Rounds Secured $24M in Series B Funding

Kentucky Patent of the Month - December 2021

The Rounds, an inventory management platform focused on recurring grocery deliveries, has secured $24 million in Series B funding in a round led by Moderne Ventures with support from FJ Labs.

The Rounds plans to use the funding to scale their AI-powered service. The company’s business model revolves around sourcing products directly from producers in bulk, refilling them in reusable packaging, and delivering them weekly through its bespoke two-way last-mile logistics network.

The company’s AI models predict the everyday items you may need refilled in your home. Recently, the company introduced AI-enabled features that allow members to customise their ‘Refill Day’ and manage product refills either on a one-time or recurring basis with the ‘Psychic Home Manager’ feature.

The Rounds has also broadened its product range with over a hundred new stock-keeping units, including fresh produce and local goods

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Farmblox Expands from Maple Syrup to Vineyards

Shortly after raising $2.5 million, Farmblox Inc. has announced plans to expand their operations from maple syrup to vineyards and orchards. The agricultural monitoring startup develops AI-based solutions to monitor crops.

The company was founded in January of 2023, with rapid growth bringing them to 55 live farm customers. Farmblox says its platform has grown tenfold in the last year as customers adopt the technology at the forefront of addressing critical challenges posing significant threats to the global food supply.

Farmblox’s technology enables remote monitoring in all weather conditions, gathering data into a simple dashboard. With data at your fingertips, farmers can identify operational issues in moments.

The seed funding will enable expansion of both their operations and their technology. The company plans to offer data on soil moisture, soil CO2, soil temperature, leak detection, tank and silo levels, ambient temperatures, freeze risk, water usage, irrigation pressure, pump conditions, and weather conditions.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Pathalys Pharma Secures $105M in Series B

Pathalys Pharma, a startup based in North Carolina, has raised $105 million in Series B funding. The round was led by TCGX and joined by other notable investors including, JP Morgan Life Sciences Private Capital, Samsara BioCapital, Marshall Wace, KB Investment, JPS Growth Investment Limited Partnership, and included support from Pathalys’ founding investors, Catalys Pacific and DaVita Venture Group.

Pathalys is building biotech focused on fighting kidney disease through their top candidate – upacicalcet. This candidate is a potentially improved calcimimetic for the treatment of SHPT (secondary hyperparathyroidism). A calcimimetic imitates the effects of calcium on tissues, making them excellent tools for treating problems linked to calcium homeostasis or skeletal integrity.

Upacicalcet is a novel calcimimetic which would be delivered intravenously after hemodialysis. If it operates properly, it would reduce levels of PTH and improve the tolerability profile for patients. The candidate has moved into Phase 3 Studies, with two identical 375-person trials.

The biotech stated that the additional funding will be utilized to complete those studies, start the process of getting ready to submit an application for FDA approval, and “accelerate preapproval commercialisation preparations.”

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Impossible Sensing Begins Field Testing of Soil Sensor

State of the art R&D center opens in Iowa

Impossible Sensing, a St.Louis startup, has officially launched field tests for their second-generation prototype sensor. The testing will take place at Reckamp Farms in Wright City, west of St. Louis.

Impossible Sensing is a space technology company focused on exploring every and all environments – from deep space to deep ocean. To achieve this, they create proprietary sensing technologies that gather data which could be used to mitigate climate change.

“This is the first time this goes to the real world,” said Pablo Sobron, who founded Impossible Sensing. “We tested it in the lab, in the backyard in the city, and now it’s coming to a farm.”

The tests on Thursday consisted of digging a hole a few inches deep and then firing a high-powered laser that can measure the specific soil conditions at around 30 different sites.

It’s different from how farmers typically test their soil by collecting samples every few acres, Sobron said. The level of granularity from his instrument can reveal variations in nutrient levels and soil conditions in the same field and could prove the catalyst to unlocking some of the loftiest goals of precision agriculture, he said.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Slingshot AI Secures $30M in Seed Funding

Slingshot AI has reportedly raised $30 million in a seed funding round led by Andreessen Horowitz. The round also saw participation from Felicis Ventures, BoxGroup, Gokul Rajaram, Jerry Murdock, Bryan Baum, Sumeet Gajri, Arjun Sethi, Mike Stoppelman, Liu Jiang, Cory Levy, and David Cahn.

The AI mental health startup, based in both New York and London, plans to use the seed funding to expand operations and increase development efforts.

Slingshot AI was founded to build solutions for mental healthcare using AI. To achieve this, they are building AI models to delve into human psychology and learn more about human nature. Their goal is to help people change their minds and take on any challenge that arises.

At present, the startup partners with organizations around the globe to bring their technology to real use. These applications have included AI-assisted crisis text response and AI counseling. In parallel, these applications build real datasets to further power the startup’s models.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

BeMe Health Secures $12.5M for Teen Mental Health

BeMe Health, a Miami startup, has secured $12.5 million in anticipation of a Series A funding round. The funding comes from growth capital investor Hesperia Capital.

The startup is a teen-focused digital mental health provider focused on fighting the growing mental health epidemic.

“BeMe takes a different approach to the mental health issues faced during this formative stage of life and is laying the groundwork for healthier futures,” Michael Papile, co-founder of Hesperia Capital, said in a news release.

The company plans to use the funding to improve its technology and begin marketing. The technology suite includes age-specific support content and interactive tools to help maintain mental wellness.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Maui Imaging Secures $4M DOD Contract, Emerges from Stealth

Maui Imaging, a Tucson-based startup, has emerged from stealth mode with a $4 million DOD contract. The company has been building an ultrasound system capable of visualizing the anatomy that others cannot.

MAUI was founded in 2006, bringing together experts in the fields of sonar, radar, electrical engineering, and medical imaging. With experts in line, the startup began their research, building their breakthrough Computed Echo Tomography (CET).

Since their founding, they have achieved more than 160 U.S. and international patents. Their latest, FDA cleared product has caught the attention of the Department of Defense. Their K3900 imaging system is being tested to aid military medical personnel in diagnosing and treating traumatic injuries.

One crucial application being tested by the DOD and clinical studies is thanks to the technology’s ability to image through the skull without a significant fracture or surgically removing bone. This would be beneficial when soldiers need clinical insight but cannot access advanced imaging.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Holonym Foundation Secures $5.5M in Seed Funding for Human Keys

Delaware’s Holonym Foundation has announced a successful $5.5 million seed funding round. The round was led by Finality Capital and Paper Ventures, with participation from Arrington Capital, Draper Dragon, Lightshift and more.

The startup is building the next generation of digital identity security for a decentralized web. The idea? To build the core principles needed to enable citizens with a digital identity to prove their personhood. How? Using cryptography.

Cryptographic keys secure every digital interaction on the internet. Holonym plans to use this premise in a more sophisticated way. Their “Human Keys” approach turns humans into keys rather than creating private keys from random phrases. This new framing shifts ownership of digital assets from the holder of a random seed, to the human that can uniquely prove their biometrics. Human Keys make the ownership layers of the internet built on top more consumer-friendly, decentralized, and secure. This new framing shifts ownership of digital assets from the holder of a random seed, to the human that can uniquely prove their biometrics. Human Keys make the ownership layers of the internet built on top more consumer-friendly, decentralized, and secure.

Shady El Damaty, co-founder of Holonym, says this is just the start for the Holonym Foundation. “Human Keys will redefine how citizens interact with the internet by limiting the overreach of power and hardening individual rights with resilient decentralized protocols built on Zeronym and Mishti Network.”

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

NephSol Secures the Win at Alabama’s Launchpad Concept Pitch

Global Microbiology Industry Projected to Grow Due to R&D Expenditure and Innovation

NephSol Inc. has secured $25,000 after winning the concept stage of Alabama’s Launchpad Cycle 2 2024.

The company competed in a field of eight finalists on August 15. The Launchpad program is part of the Economic Development Partnership of Alabama (EDPA) in partnership with Innovate Alabama.

NephSol pitched their project which aims to revolutionize dialysis care with a headset designed to monitor cerebral blood flow during treatments. The company aims to reduce severe side effects and mortality rates associated with dialysis due to decreased blood flow in the brain.

“Winning Alabama Launchpad is the next big step for our company,” said Sydeny Ringold, co-founder of NephSol. “It means we will be able to complete our regulatory process filings – a step needed for a medical device company. We are beyond excited to finally check that off, move forward and potentially go to market very quickly.”

Each finalist company received two months of intensive mentorship, through both one-on-one and group session training with startup founders and business experts, to prepare for the finale judging panels.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Alaska Airlines Invests in JetZero

Stratodynamics Shows Pomise in Unmanned Aerial Turbulence Detection

JetZero has secured new investment funding from Alaska Airlines. The aircraft engineering startup is developing a blended-wing aircraft design to reduce carbon emissions and fuel burn by as much as 50%.

The investment came through Alaska Airlines’ venture capital subsidiary Alaska Star Ventures includes options for future aircraft orders. The total value of the investment has not been revealed.

The blended-wing design combines the winds with the fuselage, creating a smoother overall shape which reduces drag and weight. The design also affords extra width in the fuselage which opens up possibilities for cabin layouts.

“At Alaska, we are always looking for ways to innovate and shape the future of air travel for our guests, employees, and industry,” said senior vice president of public affairs and sustainability Diana Birkett Rakow. “We are proud to invest in JetZero’s development of this innovative next-generation aircraft, with a significant step-change in fuel efficiency.”

Long Beach-based JetZero was founded in 2021 by Mark Page, who led the first NASA-funded blended-wing design initiative, and by Tom O’Leary, former COO of electric air taxi startup Beta Technologies. JetZero is targeting a 2030 launch for its aircraft.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.